000 | 02183 a2200637 4500 | ||
---|---|---|---|
005 | 20250515184029.0 | ||
264 | 0 | _c20091202 | |
008 | 200912s 0 0 eng d | ||
022 | _a1471-2407 | ||
024 | 7 |
_a10.1186/1471-2407-9-303 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScartozzi, Mario | |
245 | 0 | 0 |
_aEpidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis. _h[electronic resource] |
260 |
_bBMC cancer _cAug 2009 |
||
300 |
_a303 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aErbB Receptors _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Dosage |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aBearzi, Italo | |
700 | 1 | _aMandolesi, Alessandra | |
700 | 1 | _aPierantoni, Chiara | |
700 | 1 | _aLoupakis, Fotios | |
700 | 1 | _aZaniboni, Alberto | |
700 | 1 | _aNegri, Francesca | |
700 | 1 | _aQuadri, Antonello | |
700 | 1 | _aZorzi, Fausto | |
700 | 1 | _aGalizia, Eva | |
700 | 1 | _aBerardi, Rossana | |
700 | 1 | _aBiscotti, Tommasina | |
700 | 1 | _aLabianca, Roberto | |
700 | 1 | _aMasi, Gianluca | |
700 | 1 | _aFalcone, Alfredo | |
700 | 1 | _aCascinu, Stefano | |
773 | 0 |
_tBMC cancer _gvol. 9 _gp. 303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-9-303 _zAvailable from publisher's website |
999 |
_c19113885 _d19113885 |